Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Endothelial nitric oxide synthase in vascular disease: from marvel to menace
Because these are model-based contexts, interpretation must remain model-bound
Targeting CYP51A1: small-Molecule inhibitors and therapeutic potential The cholesterol biosynthetic pathway has proven to be a successful target in drug development, as exemplified by statins for hypercholesterolemia and azole antifungals for infectious diseases [97, 98]
Oral supplements have limited absorption compared to IV injections, but may still offer antioxidant support
Concentrated (10 mg/mL) minimises injection volumes but requires precise syringe measurements
US$ 22.94
US$ 23.56
US$ 28.45
US$ 28.81
